6505--Sacubitril/Valsartan Tablets (VA-27-00014055)
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NAC PHARMACEUTICALS (36E797)
Contract Value
Not provided
Codes & Classification
Solicitation Number
36E79727R0007
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents2
The Department of Veterans Affairs (VA), through its Enterprise Procurement Office, has issued a presolicitation notice for an upcoming Request for Proposal (RFP) under procurement identifier 36E79727R0007. This procurement seeks to establish an unrestricted contract for the supply of Sacubitril/Valsartan Tablets, a pharmaceutical product used in the treatment of heart failure, to support the needs of multiple federal healthcare entities. The scope of this contract encompasses the VA—including its Consolidated Mail Order Pharmacies (CMOPs) and State Veterans Homes (SVH)—as well as the Department of Defense (DoD) with its Tricare Mail Order Pharmacies (TMOPs), the Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC).
The primary objective of this procurement is to secure a reliable, uninterrupted supply of Sacubitril/Valsartan Tablets for distribution through the VA and DoD’s respective Pharmaceutical Prime Vendor Programs. The contract will be awarded to a single responsible offeror capable of meeting all requirements, with a base period of one year and four additional pre-priced one-year option periods, ensuring continuity and flexibility over a potential five-year lifecycle.
Key requirements for offerors include the necessity to supply the drug under the exact name as it appears on the product label, accompanied by a unique National Drug Code (NDC) specific to the offeror. The successful contractor’s label and NDC will be the sole identifiers on the product, and relabeling over another manufacturer’s label is strictly prohibited. VA labels must be able to securely adhere atop the contractor’s label, and packaging specifications are detailed: all unit-of-use bottles (60 and 180 count) must feature a safety cap that can be converted to a non-safety cap, with a minimum bottle volume of 120cc. The bottle must have a cylindrical body with a minimum circumference of 5.75 inches and accommodate a label sized 5.25 x 2 inches, with an additional 0.5 inch to ensure barcode, expiration date, and lot number visibility.
This acquisition is subject to the World Trade Organization Government Procurement Agreement and relevant Free Trade Agreements, reflecting the federal government’s commitment to international procurement standards. The solicitation will be issued electronically in commercial item format in accordance with FAR Part 12, with no paper copies available. Offerors are encouraged to monitor SAM.gov for amendments and updates.
The procurement is classified under NAICS code 325412 (Pharmaceutical Preparation Manufacturing), with product service code 6505. The contracting entity is NAC Pharmaceuticals (36E797), a federal office within the Department of Veterans Affairs. The primary point of contact for this opportunity is James Sullivan, Contract Specialist, who can be reached at [email protected] or 708-786-5239.
The anticipated solicitation release date is December 18, 2026, with a tentative closing date of January 7, 2027. All responsible sources may submit a timely offer for consideration. Contractors interested in this opportunity should ensure their capabilities align with the stringent labeling, packaging, and supply continuity requirements outlined, and remain attentive to updates posted on SAM.gov.
For further information and to access the presolicitation notice, visit: https://sam.gov/opp/6ee0c937156749b0a15d03635aff62f0/view.